A detailed history of Fidelis Capital Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 2,890 shares of VRTX stock, worth $1.39 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
2,890
Previous 1,785 61.9%
Holding current value
$1.39 Million
Previous $726 Million 515.68%
% of portfolio
0.68%
Previous 0.16%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$407.69 - $446.08 $13,453 - $14,720
33 Added 1.14%
2,923 $1.22 Billion
Q1 2024

May 01, 2024

BUY
$407.69 - $446.08 $450,497 - $492,918
1,105 Added 61.9%
2,890 $4.47 Billion
Q4 2023

Jan 31, 2024

BUY
$343.0 - $410.68 $68,257 - $81,725
199 Added 12.55%
1,785 $726 Million
Q3 2023

Nov 07, 2023

BUY
$338.18 - $362.46 $64,254 - $68,867
190 Added 13.61%
1,586 $552 Million
Q2 2023

Aug 10, 2023

BUY
$314.42 - $351.91 $33,328 - $37,302
106 Added 8.22%
1,396 $491 Million
Q1 2023

May 09, 2023

BUY
$283.23 - $323.1 $365,366 - $416,799
1,290 New
1,290 $449 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $124B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Fidelis Capital Partners, LLC Portfolio

Follow Fidelis Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fidelis Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fidelis Capital Partners, LLC with notifications on news.